Zobrazeno 1 - 3
of 3
pro vyhledávání: '"James M. Kingoo"'
Autor:
Ingrid A. Beck, Molly Levine, Christine J. McGrath, Steve Bii, Ross S. Milne, James M. Kingoo, Isaac So, Nina Andersen, Sandra Dross, Robert W. Coombs, James Kiarie, Bhavna Chohan, Samah R. Sakr, Michael H. Chung, Lisa M. Frenkel
Publikováno v:
EClinicalMedicine, Vol 18, Iss , Pp - (2020)
Background: Pre-treatment HIV-drug-resistance (PDR) to WHO-recommended 1st-line non-nucleoside reverse transcriptase inhibitors (NNRTI)-based antiretroviral treatment (ART) is increasing in low-resource communities. We evaluated the risk of PDR on tr
Externí odkaz:
https://doaj.org/article/302e55f02ef349b1a0f7c82631578d63
Autor:
Ross S. Milne, Molly Levine, Lisa M. Frenkel, Sandra Dross, Nina Andersen, Michael H. Chung, Samah R. Sakr, James Kiarie, Ingrid A. Beck, Isaac So, Robert W. Coombs, Steve Bii, Bhavna Chohan, Christine J. McGrath, James M. Kingoo
Publikováno v:
EClinicalMedicine, Vol 18, Iss, Pp-(2020)
EClinicalMedicine
EClinicalMedicine
Background: Pre-treatment HIV-drug-resistance (PDR) to WHO-recommended 1st-line non-nucleoside reverse transcriptase inhibitors (NNRTI)-based antiretroviral treatment (ART) is increasing in low-resource communities. We evaluated the risk of PDR on tr
Autor:
Molly Levine, Lisa M. Frenkel, Horacio A. Duarte, Catherine Kiptinness, James M. Kingoo, Samah R. Sakr, Michael H. Chung, Bhavna Chohan, Ingrid A. Beck
Publikováno v:
AIDS (London, England). 32(16)
Objectives An increasing prevalence of HIV pretreatment drug resistance (PDR) has been observed in Africa, which could decrease the effectiveness of antiretroviral therapy (ART) programs. We describe our experiences, the costs and challenges of imple